L-743,872

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Candidiasis, EsophagealCandidiasis, OralHIV Infections

Phase 2

Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole

TerminatedNCT00005920

Merck Sharp & Dohme LLCCandidiasis, Oral, HIV Infections

Target: 70Updated: 2005-06-24

Unknown Phase

A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis

CompletedNCT00005921

Merck Sharp & Dohme LLCCandidiasis, Esophageal, HIV Infections

Target: 18Updated: 2005-06-24